// App-Quantinova.ai

6072 : Tumors flare-up and patterns of recurrence in patients (pts) with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) treated with anti-PD1/PD-L1 inhibitors.

Researchers

Presenter

  • Esma Saada-Bouzid

Principal Investigators

  • Cecile Defaucheux

  • Andy Karabajakian

  • Virginia Palomar Coloma

  • Vincent Servois

  • Xavier Paoletti

  • Caroline Even

  • Jerome Fayette

  • Joel Guigay

  • Delphine Loirat

  • Emanuela Romano

  • Christophe Le Tourneau

Medical Centers

  • Centre Antoine-Lacassagne, Nice, France

  • Institut Curie, Paris Cedex, France

  • Centre Leon Berard, Lyon, France

  • Institut Gustave-Roussy, Villejuif, France

  • Gustave Roussy, Villejuif, France

  • University of Lyon, Lyon, France

  • Centre Antoine-Lacassagne, Nice, France

  • CH Lausanne, Lausanne, Switzerland

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim